Vancouver, B.C., December 20, 2019 – WELL Health Technologies Corp. (the “Company” or “WELL”) (TSX.V: WELL), a company focused on consolidating and modernizing clinical and digital assets within the primary healthcare sector, is pleased to announce it has received conditional approval from the Toronto Stock Exchange (the “TSX”) to list its common shares on the TSX and delist from the TSX Venture Exchange (the “TSX-V”). Final approval of the listing is subject to the Company meeting certain standard TSX listing requirements.
“We are delighted to be graduating from the TSX-V and onto the TSX,” said Mr. Shahbazi, Chairman and CEO of WELL Health. “The TSX is one of the world’s premier stock exchanges and allows us to significantly expand our shareholder base and trading liquidity. We would also like to thank the TSX-V as we are grateful to have been provided the opportunity to start and develop our business on what we believe is the world’s best equity market for early stage companies.”
WELL expects to satisfy all of the listing requirements in early January 2020, and will make a further announcement once the TSX has confirmed the date on which trading will commence on the TSX. The TSX has also confirmed that WELL’s common shares will continue to trade under the stock symbol “WELL” upon listing on the TSX.
WELL HEALTH TECHNOLOGIES CORP.
Per: “Hamed Shahbazi”
Hamed Shahbazi
Chief Executive Officer, Chairman and Director
About WELL
WELL is a unique company that operates Primary Healthcare Facilities as well as a significant EMR or Electronic Medical Records business that supports the digitization of such clinics. WELL owns and operates 20 medical clinics, is a majority owner of SleepWorks Medical and provides digital Electronic Medical Records (EMR) software and services to 946 medical clinics across Canada. WELL’s overarching objective is to empower doctors to provide the best and most advanced care possible while leveraging the latest trends in digital health. WELL is publicly traded on the TSX Venture Exchange under the symbol “WELL.v”. WELL was recognized as a TSX Venture 50 Company in 2018 and 2019.
Forward-Looking Statements
This news release may contain “forward-looking statements” within the meaning of applicable Canadian securities laws, including, without limitation: statements relating to the up-listing to the TSX; the benefits of such listing; receipt of final approval; and the date thereof. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic and competitive uncertainties, and contingencies. These statements generally can be identified by the use of forward-looking words such as “may”, “should”, “will”, “could”, “intend”, “estimate”, “plan”, “anticipate”, “expect”, “believe” or “continue”, or the negative thereof or similar variations. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause future results, performance or achievements to be materially different from the estimated future results, performance or achievements expressed or implied by those forward-looking statements and the forward-looking statements are not guarantees of future performance. WELL’s statements expressed or implied by these forward-looking statements are subject to a number of risks, uncertainties, and conditions, many of which are outside of WELL ‘s control, and undue reliance should not be placed on such statements. Forward-looking statements are qualified in their entirety by the inherent risks and uncertainties including: adverse market conditions; risks inherent in the primary healthcare sector in general; inability to satisfy listing conditions; and the risk factors noted in the Company’s MD&A and other public disclosure documents filed on SEDAR. Except as required by securities law, WELL does not assume any obligation to update or revise any forward-looking statements, whether as a result of new information, events or otherwise.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
For further information:
Pardeep S. Sangha
Vice President Corporate Strategy and Investor Relations
604-628-7266
